Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05438277 · ClinicalTrials.gov registry record · Phase 4
Pain Increases After Shoulder Injection
A Phase 4 study, sponsored by Campbell Clinic.
- Completed
- Registry status
- Phase 4
- Development phase
- 421
- Enrollment target
NCT05438277: Completed Phase 4 study, sponsored by Campbell Clinic.
NCT05438277 is a Phase 4 study that has completed, run by Campbell Clinic. The registered enrollment target is 421 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (19% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05438277, a Phase 4 study, has completed, sponsored by Campbell Clinic.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 421 participants
- Enrollment target
Study Summary
Compare FLARE reactions (increase in VAS by two or more points) in the first 48 hours following a shoulder injection.
Primary Outcome
A flare reaction was defined as an increase of two or more points of Visual Analog Score (VAS) score during the first week following injection. The VAS is a patient reported pain score from zero to ten where zero is no pain and ten is the most pain.
Interventions
- DRUG Methylprednisolone (MPA)
- DRUG Triamcinolone Acetonide (TA)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 421 participants |
| Start Date | 2020-01-01 |
| Est. Completion | 2022-09-30 |
| Phase | Phase 4 |
What the finished NCT05438277 record still lists
NCT05438277 is an interventional study that assigns participants to a tested intervention. The registered 421 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (19% lower).
The record links to 0 conditions, and to 2 interventions - of which Methylprednisolone (MPA) is the first listed.
NCT05438277 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05438277 about?
NCT05438277 is a clinical study titled "Pain Increases After Shoulder Injection". Compare FLARE reactions (increase in VAS by two or more points) in the first 48 hours following a shoulder injection.
What is the current status of trial NCT05438277?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 421 participants. The study started on 2020-01-01. Estimated completion is 2022-09-30.
What interventions are being tested in trial NCT05438277?
The interventions under investigation include: Methylprednisolone (MPA) (DRUG), Triamcinolone Acetonide (TA) (DRUG).
Who is sponsoring clinical trial NCT05438277?
This trial is sponsored by Campbell Clinic, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05438277's enrollment target sits among peer trials
421 201st of 2000 higher than 1,800 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05976763 · 421 participants · Phase 3
Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for Older Patients With Previously Untreated Mantle Cell Lymphoma
- NCT07114601 · 421 participants · Phase 1
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
- NCT04763356 · 422 participants · NA
Remote Monitoring and Management of Chemotherapy Induced Peripheral Neuropathy
- NCT06837246 · 422 participants · NA
A Clinical Trial to Assess Cognitive Effects of Cognitive Nutritional Supplement in General Population
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI